Literature DB >> 21695410

Ethical Dilemmas and End-of-Life Choices for Patients with Implantable Cardiac Devices: Decisions Regarding Discontinuation of Therapy.

Blair P Grubb1, Beverly Karabin.   

Abstract

OPINION STATEMENT: It is our belief that a well-designed cardiac device management program should include end-of-life patient and family planning, addressing potential decisions regarding withdrawal of pacemaker and/or implantable cardioverter defibrillator therapy. Guided by the basic ethical and legal principles outlined in the article, it is the responsibility of the electrophysiologist and other involved health care providers to introduce this topic to patients, provide guidance and resources for decision making, and honor both patient and family requests.

Entities:  

Year:  2011        PMID： 21695410     DOI： 10.1007/s11936-011-0136-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  16 in total

1.  HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.

Authors:  Rachel Lampert; David L Hayes; George J Annas; Margaret A Farley; Nathan E Goldstein; Robert M Hamilton; G Neal Kay; Daniel B Kramer; Paul S Mueller; Luigi Padeletti; Leo Pozuelo; Mark H Schoenfeld; Panos E Vardas; Debra L Wiegand; Richard Zellner
Journal:  Heart Rhythm       Date:  2010-05-14       Impact factor: 6.343

Review 2.  Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations.

Authors:  Susanne S Pedersen; Krista C van den Broek; Samuel F Sears
Journal:  Pacing Clin Electrophysiol       Date:  2007-12       Impact factor: 1.976

3.  Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.

Authors:  G Neal Kay; Gregory T Bittner
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06

4.  Patients' attitudes toward implanted defibrillator shocks.

Authors:  M Ahmad; L Bloomstein; M Roelke; A D Bernstein; V Parsonnet
Journal:  Pacing Clin Electrophysiol       Date:  2000-06       Impact factor: 1.976

5.  Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Dan W Brock; William H Maisel
Journal:  Heart Rhythm       Date:  2010-07-19       Impact factor: 6.343

6.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

7.  Abandonment at the end of life from patient, caregiver, nurse, and physician perspectives: loss of continuity and lack of closure.

Authors:  Anthony L Back; Jessica P Young; Ellen McCown; Ruth A Engelberg; Elizabeth K Vig; Lynn F Reinke; Marjorie D Wenrich; Barbara B McGrath; J Randall Curtis
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Making difficult discussions easier: using prognosis to facilitate transitions to hospice.

Authors:  Esmé Finlay; David Casarett
Journal:  CA Cancer J Clin       Date:  2009-06-17       Impact factor: 508.702

9.  The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.

Authors:  Samuel F Sears; Lauren D Vazquez Sowell; Emily A Kuhl; Adrienne H Kovacs; Eva R Serber; Eileen Handberg; Shawn M Kneipp; Issam Zineh; Jamie B Conti
Journal:  Pacing Clin Electrophysiol       Date:  2007-07       Impact factor: 1.976

10.  "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.

Authors:  Nathan E Goldstein; Davendra Mehta; Ezra Teitelbaum; Elizabeth H Bradley; R Sean Morrison
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.